Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RETIFANLIMAB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

63.2%
Female
36.8%
Male

Age Information

The average age of patients reporting adverse events with RETIFANLIMAB is 59.5 years.

Geographic Distribution

The majority of adverse event reports for RETIFANLIMAB originate from GB.

Report Summary & Outcomes

96
Total Reports
96
As Primary/Secondary Suspect
17
Deaths Reported
89
Hospitalizations
13
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20191118. Most recent report: 20240421. View full timeline →

More About RETIFANLIMAB

RETIFANLIMAB Full Profile Reports by Year Drug Interactions